← FDA DRUG APPROVALS
FDA NDA · NDA216227
IHEEZO
chloroprocaine hydrochloride ophthalmic gel
Sponsor: HARROW EYE
APPLICATION
NDA216227
TYPE
NDA
ORIGINAL APPROVAL
2022-09-27
LATEST ACTION
2022-09-27
ROUTE
OPHTHALMIC
DOSAGE FORM
GEL
MARKETING STATUS
Prescription
Products
IHEEZO · ReferencePrescription
CHLOROPROCAINE HYDROCHLORIDE 3% · GEL · OPHTHALMIC
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.